Protalix Biotherapeutics Inc (PLX)

Cash Conversion Ratio

-2.91×

Quarterly · Period ending:

PLX logo

PLX Cash Conversion Ratio

Latest reported-2.91×
PLX Quarterly Cash Conversion Ratio (59.40× → -2.91×)
High-resolution chart · PNG

PLX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Protalix Biotherapeutics Inc Cash Conversion Ratio — Quarterly
Period endingCash Conversion Ratio
-2.9105×
1.1609×
-0.2956×
-1.7962×
-34.5366×
1.4822×
0.5491×
1.2417×
1.7167×
-0.7813×
-0.5534×
3.9606×
0.2466×
1.0367×
0.7551×
2.5966×
1.4031×
2.65×
0.8302×
0.5296×
-0.5547×
1.8667×
-19.7103×
0.8352×
1.939×
-4.3089×
-12.7663×
1.016×
0.6725×
1.0251×
-0.4286×
-2.5432×
0.9583×
1.3347×
-1.1426×
0.9335×
-19.8711×
0.1462×
2.8411×
0.4938×
1.1072×
1.1486×
0.2987×
2.3005×
1.1002×
1.0918×
0.5953×
1.2227×
1.083×
1.1713×
0.456×
1.4865×
1.2883×
2.367×
-0.159×
1.6059×
585.7727×
1.2011×
0.8208×
1.029×
0.4555×
1.3048×
1.0636×
4.4555×
1.4262×
1.4967×
-3.9215×
0.6207×
-12.4764×
-3.8288×
4.8094×
2.0105×
0.2328×
1.8689×
10.9065×
1.4665×
0.5281×
89×
59.4×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.